Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 10Terminated 3Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3

Conditions

Anemia 3

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × epoetin beta × Clear all
NCT00875004 2024-06-26

PLATON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Terminated
27 enrolled
Classical hematology

Anemia

NCT02608060 2016-11-02

A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

Hoffmann-La Roche

Phase 4 Terminated
4 enrolled
Classical hematology

Anemia

NCT02624141 2016-11-02

A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy

Hoffmann-La Roche

Phase 4 Terminated
10 enrolled
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡